Development and External Validation of the FluScoreVax Risk Score for Influenza That Incorporates Vaccine Status
We developed and externally validated the FluScoreVax risk score, available as an app. It classifies 61% of patients as low risk, of whom only 7% had influenza.
Authors
- Samuel Coenen (ORCID: https://orcid.org/0000-0002-1238-8052)
- Margareta Ieven (ORCID: https://orcid.org/0000-0002-1608-0645)
- Bruce P. Barrett (ORCID: https://orcid.org/0000-0002-3953-4718)
- Paul Little (ORCID: https://orcid.org/0000-0003-3664-1873)
- Daniel Merenstein (ORCID: https://orcid.org/0000-0002-8808-6907)
- Yewen Chen (ORCID: https://orcid.org/0000-0001-9969-5137)
- Mark H. Ebell (ORCID: https://orcid.org/0000-0003-3228-2877)
- Ye Shen (ORCID: https://orcid.org/0000-0002-4891-8801)
- Fan Luo (ORCID: https://orcid.org/0009-0006-8465-1848)
Institutions
- University of Antwerp (BE)
- University of Georgia (US)
- Infectious Diseases Institute (UG)
- University of Southampton (GB)
- Michigan State University (US)
Publication Details
- Journal
- The Journal of the American Board of Family Medicine
- Published
- 2025-05-01
- DOI
- https://doi.org/10.3122/jabfm.2024.240366r1
- Citations
- 1
- Primary Topic
- Influenza Virus Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.35
Funders
- Agency for Healthcare Research and Quality